SenokotXTRA (standardizedsenna concentrate)

Drug Facts

Active ingredient (in each tablet)Purpose

Sennosides 17.2 mg

Purpose

Laxative

Uses

relieves occasional constipation (irregularity)
generally causes bowel movement in 6-12 hours

Warnings

Do not use

laxative products for longer than 1 week unless directedby a doctor

Ask a doctor beforeuse if you have

stomach pain
nausea
vomiting
noticed a sudden change in bowel movements that continuesover a period of 2 weeks

Stop use and aska doctor if you have rectal bleeding or fail to have a bowelmovement after use of a laxative. These may indicate a serious condition.

If pregnant orbreast-feeding, ask a health professional before use.

Keep out of reachof children. In case of overdose, get medical help or contacta Poison Control Center right away.

Directions

take preferably at bedtime or as directed by a doctor

age	startingdosage	maximumdosage
adults and children 12 yearsof age and over	1 tablet once a day	2 tablets twice aday
children 6 to under 12 years	½ tablet once a day	1 tablet twice aday
children under 6	ask a doctor	ask a doctor

Other information

each tablet contains: calcium 20 mg
store at 25˚C (77˚F); excursions permitted between 15˚-30˚C(59˚-86˚F)

Inactive ingredients croscarmellosesodium, dicalcium phosphate, hypromellose, lactose, magnesium stearate,microcrystalline cellulose, mineral oil, stearic acid, talc, tartaricacid

Dist. by: Avrio Health L.P., Stamford, CT 06901-3431

Senokot® Extra Strength
36 Tablets Carton

Senokot® Extra Strength
12Tablets Carton

Senokot® Extra Strength 36 Tablets Label

SENOKOT
standardized senna concentrate tablet, film coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:67618-120
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	17.2 mg

Ingredient Name	Strength
Inactive Ingredients
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)
LACTOSE, UNSPECIFIED FORM (UNII: J2B2A4N98G)
MAGNESIUM STEARATE (UNII: 70097M6I30)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
TARTARIC ACID (UNII: W4888I119H)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
LIGHT MINERAL OIL (UNII: N6K5787QVP)
TALC (UNII: 7SEV7J4R1U)
STEARIC ACID (UNII: 4ELV7Z65AP)

Product Characteristics
Color	BROWN (Light Brown)	Score	no score
Shape	ROUND	Size	9mm
Flavor		Imprint Code	X
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:67618-120-12	1 in 1 CARTON	09/01/1988
1		12 in 1 BLISTER PACK; Type 0: Not a Combination Product
2	NDC:67618-120-36	3 in 1 CELLO PACK	09/01/1988	01/01/2023
2		12 in 1 BLISTER PACK
2		12 in 1 BLISTER PACK; Type 0: Not a Combination Product
3	NDC:67618-120-06	36 in 1 BOTTLE; Type 0: Not a Combination Product	09/01/1988

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
OTC Monograph Drug	M007	09/01/1988

Labeler - Atlantis Consumer Healthcare, Inc. (118983925)

Registrant - Atlantis Consumer Healthcare, Inc. (118983925)